Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160394
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2005-09-09
Brief Title:
Comparison of Duac Gel And Differin Gel in Mild to Moderate Acne Vulgaris
Sponsor:
Stiefel a GSK Company
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Multi-Centre Single-Blind Parallel Group Clinical Evaluation of the Efficacy and Safety of Duac Gel And Differin Gel in the Topical Treatment of Mild to Moderate Acne Vulgaris
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Comparing the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate equivalent to 1 clindamycin and benzoyl peroxide 5 once daily with a gel containing 01 adapalene once daily in the treatment of acne vulgaris of mild to moderate severity
Detailed Description:
Title A Multi-Centre Single-Blind Parallel Group Clinical Evaluation of the Efficacy and Safety of Duac Gel a Gel Containing Clindamycin Phosphate Equivalent to 1 Clindamycin and 5 Benzoyl Peroxide And Differin Gel a Gel Containing 01 Adapalene in the Topical Treatment of Mild to Moderate Acne Vulgaris
Objectives To compare the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate equivalent to 1 clindamycin and benzoyl peroxide 5 once daily with a gel containing 01 adapalene once daily in the treatment of acne vulgaris of mild to moderate severity
Study methodology Randomised comparator-controlled single-blind trial The Investigators Assessors will be blinded to the treatment received
Study population Male and female patients aged 12-39 with mild to moderate acne vulgaris
Objectives To compare the efficacy and safety of a gel formulation containing a combination of clindamycin phosphate equivalent to 1 clindamycin and benzoyl peroxide 5 once daily with a gel containing 01 adapalene once daily in the treatment of acne vulgaris of mild to moderate severity
Study methodology Randomised comparator-controlled single-blind trial The Investigators Assessors will be blinded to the treatment received
Study population Male and female patients aged 12-39 with mild to moderate acne vulgaris
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None